Federal Register Notice: FDA is making changes to its Office of Orphan Products Development grant program for fiscal year 2006. This supersedes an 8/8/03 Federal Register notice. There are new submission requests and requirements for this grant program, including a requested letter of intent, a change in funding levels, a change in number of receipt dates, and changes in review criteria. To view this notice, click here.
